Trials / Not Yet Recruiting
Not Yet RecruitingNCT07143786
Human Induced Neural Stem Cell-derived Exosomes for Treating Acute Ischemic Stroke
Human Induced Neural Stem Cell-derived Exosomes for Treating Acute Ischemic Stroke: an Exploratory Clinical Trial
- Status
- Not Yet Recruiting
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 38 (estimated)
- Sponsor
- Xuanwu Hospital, Beijing · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
A phase I/IIa clinical trial investigating the safety and preliminary efficacy of intravenous administration of human induced neural stem cell-derived exosomes for acute ischemic stroke
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | iNSC-EV01 | Intravenous induced neural stem cell-derived exosome |
| DRUG | Placebo | iNSC-EV01 mimics |
Timeline
- Start date
- 2025-10-01
- Primary completion
- 2027-07-31
- Completion
- 2027-12-31
- First posted
- 2025-08-27
- Last updated
- 2025-08-27
Source: ClinicalTrials.gov record NCT07143786. Inclusion in this directory is not an endorsement.